TIPE2 suppresses adipogenesis via METTL14-mediated m6A methylation and represents a potential therapeutic target for obesity

Abstract Despite conserved mechanisms maintaining energy homeostasis, the global obesity epidemic continues to rise. Tumor necrosis factor-α-induced protein 8-like 2 (TIPE2) is an anti-inflammatory regulator essential for immune homeostasis, yet its role in adipogenesis remains unclear. Here, we show that TIPE2 expression in human adipose tissue is inversely correlated with body mass index (BMI) and metabolic dysfunction. In mice, Tipe2 deficiency exacerbates diet-induced obesity, hyperglycaemia, and insulin resistance, whereas systemic AAV-mediated TIPE2 overexpression alleviates these phenotypes. In vitro, TIPE2 suppresses adipogenic differentiation in primary preadipocytes. Mechanistically, TIPE2 regulates N6-methyladenosine (m6A) via m6A methyltransferase-like 14 (METTL14). Loss of TIPE2 reduces m6A levels and METTL14 expression, whereas METTL14 restoration reverses the pro-adipogenic effects. Furthermore, TIPE2 modulates adipogenesis through peroxisome proliferator-activated receptor-γ (PPAR-γ) signaling. Together, these findings identify TIPE2 as a suppressor of adipogenesis via coordinated regulation of METTL14-dependent m6A modification and PPAR-γ signaling.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-16
DOI
https://doi.org/10.21203/rs.3.rs-11199357/v1
Primary Topic
Adipokines, Inflammation, and Metabolic Diseases
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

TIPE2 suppresses adipogenesis via METTL14-mediated m6A methylation and represents a potential therapeutic target for obesity

Chuanjie Liang, Wenxiu Tian, Patricia Aspichueta, Wei Hou et al.
Research Square
Adipokines, Inflammation, and Metabolic Diseases
preprint

TIPE2 suppresses adipogenesis via METTL14-mediated m6A methylation and represents a potential therapeutic target for obesity

Chuanjie Liang, Wenxiu Tian, Patricia Aspichueta, Wei Hou, Wenxiang Zheng, Chuanqin Shi, Yang Wang, Xinxin Xiang, Wing-Kin Syn, Xiaodong Zhao, Tianchu Li
preprint en

Abstract

Abstract Despite conserved mechanisms maintaining energy homeostasis, the global obesity epidemic continues to rise. Tumor necrosis factor-α-induced protein 8-like 2 (TIPE2) is an anti-inflammatory regulator essential for immune homeostasis, yet its role in adipogenesis remains unclear. Here, we show that TIPE2 expression in human adipose tissue is inversely correlated with body mass index (BMI) and metabolic dysfunction. In mice, Tipe2 deficiency exacerbates diet-induced obesity, hyperglycaemia, and insulin resistance, whereas systemic AAV-mediated TIPE2 overexpression alleviates these phenotypes. In vitro, TIPE2 suppresses adipogenic differentiation in primary preadipocytes. Mechanistically, TIPE2 regulates N6-methyladenosine (m6A) via m6A methyltransferase-like 14 (METTL14). Loss of TIPE2 reduces m6A levels and METTL14 expression, whereas METTL14 restoration reverses the pro-adipogenic effects. Furthermore, TIPE2 modulates adipogenesis through peroxisome proliferator-activated receptor-γ (PPAR-γ) signaling. Together, these findings identify TIPE2 as a suppressor of adipogenesis via coordinated regulation of METTL14-dependent m6A modification and PPAR-γ signaling.

Research Square
University of the Basque Country (ES), Central Hospital of Zibo (CN), Qilu Medical University (CN), Saint Louis University (US)
Adipokines, Inflammation, and Metabolic Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
TIPE2 suppresses adipogenesis via METTL14-mediated m6A methylation and represents a potential therapeutic target for obesity — Chuanjie Liang, Wenxiu Tian, et al. · Research Square (2026) | TGRS Research Map | TGRS